Honokiol Suppresses Renal Cancer Cells' Metastasis via Dual-Blocking Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties through Modulating miR-141/ZEB2 Signaling

被引：50
|
作者：
Li, Weidong [1 ]
Wang, Qian [2 ]
Su, Qiaozhen [3 ]
Ma, Dandan [4 ]
An, Chang [3 ]
Ma, Lei [1 ]
Liang, Hongfeng [3 ]
机构：
[1] Guangzhou Med Univ, CCGMU, Affiliated Canc Hosp, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Fac Med, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Internal Med Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
来源：
MOLECULES AND CELLS | 2014年 / 37卷 / 05期
关键词：
cancer stem cell; epithelial-mesenchymal transition; honokiol; microRNA; renal cell carcinoma; ANTICANCER AGENTS; INVASION ASSAYS; CARCINOMA; MICRORNAS; PATHWAYS; COMBINATION; MIGRATION; TARGETS; MIR-124; GLIOMA;
D O I：
10.14348/molcells.2014.0009
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Renal cell carcinoma (RCC) is associated with a high frequency of metastasis and only few therapies substantially prolong survival. Honokiol, isolated from Magnolia spp. bark, has been shown to exhibit pleiotropic anticancer effects in many cancer types. However, whether honokiol could suppress RCC metastasis has not been fully elucidated. In the present study, we found that honokiol suppressed renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties. In addition, honokiol inhibited tumor growth in vivo. It was found that honokiol could up-regulate miR-141, which targeted ZEB2 and modulated ZEB2 expression. Honokiol reversed EMT and suppressed CSC properties partly through the miR-141/ZEB2 axis. Our study suggested that honokiol may be a suitable therapeutic strategy for RCC treatment.
引用
收藏
页码：383 / 388
页数：6
相关论文
共 50 条
  • [31] Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
    Tanaka, Shota
    Hosokawa, Mika
    Yonezawa, Takeshi
    Hayashi, Wataru
    Ueda, Kumiko
    Iwakawa, Seigo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (03) : 435 - 440
  • [32] KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2
    Sun, Lan
    Zhou, Xiaona
    Li, Yanmeng
    Chen, Wei
    Wu, Shanna
    Zhang, Bei
    Yao, Jingyi
    Xu, Anjian
    CELL ADHESION & MIGRATION, 2020, 14 (01) : 182 - 194
  • [33] Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition
    Jin, Wook
    CELLS, 2020, 9 (01)
  • [34] miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer
    Hong-yuan, W.
    Xiao-ping, C.
    INDIAN JOURNAL OF CANCER, 2015, 52 (07) : 168 - 171
  • [35] The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
    Gao, Yanyan
    Zhao, Yaping
    Zhang, Juechao
    Lu, Yang
    Liu, Xin
    Geng, Pengyu
    Huang, Baiqu
    Zhang, Yu
    Lu, Jun
    SCIENTIFIC REPORTS, 2016, 6
  • [36] The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1
    Yanyan Gao
    Yaping Zhao
    Juechao Zhang
    Yang Lu
    Xin Liu
    Pengyu Geng
    Baiqu Huang
    Yu Zhang
    Jun Lu
    Scientific Reports, 6
  • [37] Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells
    Gunes, Canan Eroglu
    Guclu, Ebru
    Vural, Hasibe
    Kurar, Ercan
    GENE, 2021, 805
  • [38] Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer
    Lee, J-Y
    Park, M. K.
    Park, J-H
    Lee, H. J.
    Shin, D. H.
    Kang, Y.
    Lee, C. H.
    Kong, G.
    ONCOGENE, 2014, 33 (10) : 1325 - 1335
  • [39] Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFB signaling pathway
    Yu, Jiachuan
    Luo, Yuanyuan
    Wen, Qingping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [40] EPITHELIAL-MESENCHYMAL TRANSITION IN CANCER STEM CELLS PROMOTES TUMOR GROWTH THROUGH HGF PARACRINE SIGNALING
    Rountree, Carl B.
    Ding, Wei
    You, Hanning
    HEPATOLOGY, 2009, 50 (04) : 323A - 323A
12345